Potent Preclinical Efficacy of DuoHexaBody-CD37 in B-Cell Malignancies.
Saved in:
| Title: | Potent Preclinical Efficacy of DuoHexaBody-CD37 in B-Cell Malignancies. |
|---|---|
| Authors: | van der Horst HJ; Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC, VU Medical Center, Amsterdam, the Netherlands., Oostindie SC; Genmab, Utrecht, the Netherlands.; Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, the Netherlands., Cillessen SAGM; Department of Clinical Pathology, Amsterdam UMC, Amsterdam, the Netherlands., Gelderloos AT; Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC, VU Medical Center, Amsterdam, the Netherlands., Overdijk MB; Genmab, Utrecht, the Netherlands., Nijhof IS; Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC, VU Medical Center, Amsterdam, the Netherlands., Zweegman S; Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC, VU Medical Center, Amsterdam, the Netherlands., Chamuleau MED; Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC, VU Medical Center, Amsterdam, the Netherlands., Breij ECW; Genmab, Utrecht, the Netherlands., Mutis T; Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC, VU Medical Center, Amsterdam, the Netherlands. |
| Source: | HemaSphere [Hemasphere] 2020 Dec 09; Vol. 5 (1), pp. e504. Date of Electronic Publication: 2020 Dec 09 (Print Publication: 2021). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 101740619 Publication Model: eCollection Cited Medium: Internet ISSN: 2572-9241 (Electronic) Linking ISSN: 25729241 NLM ISO Abbreviation: Hemasphere Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
